Section Arrow
MXCT.NASDAQ
- MaxCyte
Quotes are at least 15-min delayed:2025/10/23 22:34 EDT
Regular Hours
Last
 1.62
-0.03 (-1.82%)
Day High 
1.68 
Prev. Close
1.65 
1-M High
1.865 
Volume 
525.56K 
Bid
1.62
Ask
1.71
Day Low
1.61 
Open
1.64 
1-M Low
1.455 
Market Cap 
175.90M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.67 
20-SMA 1.63 
50-SMA 1.52 
52-W High 5.2 
52-W Low 1.26 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.42/-0.30
Enterprise Value
193.07M
Balance Sheet
Book Value Per Share
1.79
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
38.63M
Operating Revenue Per Share
0.38
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ITGRInteger Holdings Corp73.89-35.22-32.28%46.63PE
QSIQuantum-Si2.2--0.000%-- 
BSXBoston Scientific Corp102.39-1.46-1.41%62.08PE
PMIPicard Medical Inc13.2+0.03+0.23%-- 
PACBPacific Biosciences of California1.95+0.11+5.98%-- 
Quotes are at least 15-min delayed:2025/10/23 22:34 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.